Caris Life Sciences CEO and chairman David Dean Halbert, celebrates the company's initial public offering and listing on the Nasdaq exchange by ringing the opening bell on Wednesday, June 18, 2025.

Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.. Caris Life Sciences has now raised $1.86 billion in capital since 2018.

Caris Life Sciences nears $2 billion in total funding for precision cancer research The Irving company’s new $400 million capital raise follows earlier investments that put its valuation near ...